Navigation Links
AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis

that this first AP study for ulcerative colitis revealed our treatment to be clinically active, despite the short seven day treatment period and the severity of the patients' disease. These results are very promising for the future development of AP for ulcerative colitis, where we plan to administer AP treatment for longer periods. Also importantly, results from this trial revealed that the treatment is very well tolerated. This is potentially good news for ulcerative colitis sufferers, who are looking for safe and effective treatment options."

AM-Pharma will continue to study the oral use of AP for ulcerative colitis in a further Phase II clinical study. Once safety and efficacy have been confirmed in a larger group of patients, AM-Pharma intends to license the product to a partner who will take on the late-stage development and worldwide commercialisation of AP.

Notes to editors:

About AM-Pharma www.am-pharma.com AM-Pharma is a biopharmaceutical company focused on the preclinical and clinical development of novel compounds in the field of severe infectious diseases and inflammatory diseases. All its products are based on endogenous molecules which have been optimised to combat disease.

AM-Pharma is currently conducting Phase II clinical trials for two products; Alkaline Phosphatase for sepsis, acute renal failure and ulcerative colitis; and Anti-microbial Peptide hLF1-11 for the prevention of infections in hemopoietic stem cell transplant patients.

AM-Pharma is based in Bunnik, The Netherlands with a staff of 20. The company is financed by, amongst others, Forbion Capital Partners, Inventages Venture Capital and Theratase plc. Once product safety and efficacy have been established, AM-Pharma will look for world-wide development and marketing partners for its products.

About Alkaline Phosphatase (AP)

The endogenous enzyme Alkaline Phosphatase is expr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial with Alkaline Phosphatase in Acute Renal Failure
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:3/5/2015)... Inc. (OTC: SIMH, SIMHD) ("Sanomedics" or the "Company"), an ... acquiring cutting-edge technology, products and services announced today that ... booth # 709 at the National Association of ... March 11-13, 2015 at Caesars Palace in ... 36 th annual NAPNAP Conference will bring over ...
(Date:3/5/2015)... NEW YORK , March 5, 2015 /PRNewswire/ ... developing novel therapies for the treatment of chronic ... clinicians and researchers to advisory roles. The panel ... Relmada,s development programs and efforts to advance the ... chronic pain. They bring expertise in a range ...
(Date:3/5/2015)... 5, 2015 LUNGevity Foundation, the nation,s ... Drug Administration,s (FDA) approval of Bristol Myers Squibb,s ... immunotherapy treatments add another critical new treatment option ... of a patient,s own immune system to fight ... specifically for patients with squamous cell lung cancer, ...
Breaking Medicine Technology:Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
... MINNEAPOLIS, Oct. 21 In conjunction with National ... Technologies Inc. and Your Safety Company have announced ... Cardiac Arrest Foundation for every HeartSine® samaritan® PAD ... Cardiac Arrest Foundation before December 31, 2009. , ...
... Symmetry Medical Inc. (NYSE: SMA ), a leading independent ... other medical markets, announced today that it will release third ... 2009 before the market opens on Thursday, November 5, 2009. ... a.m. ET on Thursday, November 5, 2009. , A ...
Cached Medicine Technology:HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation 2Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009 2
(Date:3/5/2015)... INTEGRATED Healthcare Strategies, a trusted ... in its 2015 Children’s Hospitals Executive Compensation Survey. ... positions, and the survey results are exclusive to ... data on 60 executive and director level positions, ... 7 subsidiary children’s hospitals. Additionally, it provided a ...
(Date:3/5/2015)... Leading nutritional supplement provider Metabolic ... Festival and Arnold Fitness EXPO in Columbus, ... host a display booth featuring free samples of its ... highly-popular, class-leading fat burner Synedrex. The company will also ... utilize its top-of-the-line supplements and miniature action figures of ...
(Date:3/5/2015)... Nutrition Leaders, a premier purveyor of health, ... reformulated Millennium 500 Creatine to its customers. Available from ... grade creatine supplement that has been micronized to more ... with overall strength gains in users. , Creatine is ... energy source in the body and helps fuel muscle ...
(Date:3/5/2015)... Jordan Valley Medical Center is now ... option for sudden cardiac arrest. When a patient wears ... detect any life-threatening abnormalities. If an abnormal heart rhythm ... delivering a treatment shock to restore normal rhythm to ... Valley Medical Center and the Heart and Lung Institute ...
(Date:3/5/2015)... USA (PRWEB) March 05, 2015 Kevin ... possible by the grips of drug addiction. The siblings ... support their habits, and to seek refuge during the ... using drugs, without consideration for his outward appearance, hygiene, ... addictive substances. CNY Central reported on Feb. ...
Breaking Medicine News(10 mins):Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 2Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 3
... Feb. 8 "Healing" has become a buzzword in ... book, Healing (Hawk Press, 2010), healer David Elliott ... natural state of balance and harmony that is called love."  The ... says Elliott, "but it,s true - until we love ourselves, we ...
... Ohio A new national study suggests that preschool-aged children ... they regularly engage in one or more of three specific ... and limiting their weekday television viewing time. In a ... 4-year-olds living in homes with all three routines had an ...
... has found that women with medium or low levels ... after being diagnosed with the precancerous breast condition, ductal ... Cancer , a peer-reviewed journal of the American ... hardship may benefit from psychosocial interventions that are designed ...
... ... is a 12-month MBA program focused on executive leadership. Delivered in a blended learning format ... Ken Blanchard EMBA attracts student leaders from all over the US. , ... Phoenix, AZ (PRWEB) February 5, 2010 -- The ...
... may increase the risk of developing asthma after the menopause, ... the journal Thorax . The authors base their ... use of HRT and development of asthma symptoms every two ... taking part in the French E3N study, which includes almost ...
... ... to capture the authentic heartbeat of NY Jets Quarterback Mark Sanchez for a CBS Cares ... stethoscope is a favorite in broadcasting - this may be the biggest audience to hear ... ...
Cached Medicine News:Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 2Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 3Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 4Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 5Health News:Family meals, adequate sleep and limited TV may lower childhood obesity 2Health News:Family meals, adequate sleep and limited TV may lower childhood obesity 3Health News:Family meals, adequate sleep and limited TV may lower childhood obesity 4Health News:Financial hardship contributes to diagnosis anxiety 2Health News:The Ken Blanchard Executive MBA Program at Grand Canyon University is a Unique Cohort System Creating Unusual Bonds - Begins in February 2Health News:The Ken Blanchard Executive MBA Program at Grand Canyon University is a Unique Cohort System Creating Unusual Bonds - Begins in February 3Health News:Estrogen-only HRT may increase risk of asthma after menopause 2Health News:Superbowl Heartbeat from Thinklabs Electronic Stethoscope 2
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
This unit is the finest standalone handswitch bipolar unit available....
Standard bipolar coagulator...
...
Medicine Products: